Global Gene Therapy Research Report 2019: Market Analysis, Trends, and Forecasts to 2025

News provided by

Nov 25, 2019, 13:00 ET

DUBLIN, Nov. 25, 2019 /PRNewswire/ -- The "Gene Therapy - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The Gene Therapy market worldwide is projected to grow by US$3.3 Billion, driven by a compounded growth of 32.7%.

Lentivirus, one of the segments analyzed and sized in this study, displays the potential to grow at over 25.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$125.3 Million by the year 2025, Lentivirus will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 30% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.3 Million to the region's size and clout in the next 5 to 6 years. Over US$117.2 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Lentivirus will reach a market size of US$6.5 Million by the close of the analysis period.

As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 39.2% over the next couple of years and add approximately US$797 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Key Topics Covered:

1. Market Overview

2. Focus on Select Players

3. Market Trends & Drivers

4. Global Market Perspective

Competitors identified in this market include:

American Gene Technologies Inc.
Applied Genetic Technologies Corporation
Benitec BioPharma
BioMarin Pharmaceutical, Inc.
bluebird bio, Inc.
Brammer Bio
Bristol-Myers Squibb Company
Celgene Corporation
Cellectis
CELLforCURE
CEVEC Pharmaceuticals GmbH
Chiesi Farmaceutici SpA
CSL Behring
Gensight Biologics S.A.
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Human Stem Cells Institute PJSC (HSCI)
Juno Therapeutics, Inc.
Lonza Group Ltd.
Novartis International AG
Novasep Holding SAS
Orchard Therapeutics Ltd.
Oxford Biomedica plc
REGENXBIO, Inc.
Sanofi Genzyme
Shanghai Sunway Biotech Co., Ltd.
Shenzhen SiBiono GeneTech Co., Ltd.
Shire PLC
Taxus Cardium Pharmaceuticals Group
Transgene SA
Ultragenyx Pharmaceutical, Inc.
uniQure NV
Voyager Therapeutics, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/l8mwap

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets